Should platelet function testing guide antiplatelet therapy for patients with coronary artery stenting or acute coronary syndromes?

Clinical Chemistry

Volumn 59, Issue 9, 2013, Pages 1299-1300

  Cohoon, Kevin P ^a   Heit, John A ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; CYTOCHROME P450 2C19; PRASUGREL; THIENOPYRIDINE DERIVATIVE;

ACUTE CORONARY SYNDROME; ANALYTIC METHOD; ANTICOAGULANT THERAPY; BLOOD CLOTTING PARAMETERS; CARDIOVASCULAR MORTALITY; CEREBROVASCULAR ACCIDENT; CORONARY STENT; DRUG ELUTING STENT; DRUG MEGADOSE; HEART INFARCTION; HUMAN; LIGHT TRANSMISSION AGGREGOMETRY; PATIENT IDENTIFICATION; PATIENT MONITORING; PLATELET REACTIVITY; PRACTICE GUIDELINE; REVIEW; STENT THROMBOSIS; THROMBOCYTE AGGREGATION INHIBITION; THROMBOCYTE FUNCTION; THROMBOCYTE FUNCTION ANALYZER; TREATMENT OUTCOME; VASODILATOR STIMULATED PHOSPHOPROTEIN PHOSPHORYLATION;

ACUTE CORONARY SYNDROME; BLOOD PLATELETS; HUMANS; PLATELET AGGREGATION INHIBITORS; PLATELET FUNCTION TESTS; PRACTICE GUIDELINES AS TOPIC; PYRIDINES;

EID: 84883384659     PISSN: 00099147     EISSN: 15308561     Source Type: Journal    
DOI: 10.1373/clinchem.2012.200881     Document Type: Review

References (5)

1. Breet NJ, van Werkum JW, Bouman HJ, Kelder JC, Ruven HJ, Bal ET, et al. Comparison of platelet function tests in predicting clinical outcome in patients undergoing coronary stent implantation. JAMA 2010;303:754-62.
2. Price MJ, Berger PB, Teirstein PS, Tanguay JF, Angiolillo DJ, Spriggs D, et al. Standard- vs high-dose clopidogrel based on platelet function testing after percutaneous coronary intervention: the GRAVITAS randomized trial. JAMA 2011;305:1097-105.
3. Collet JP, Cayla G, Cuisset T, Elhadad S, Range G, Vicaut E, Montalescot G. Randomized comparison of platelet function monitoring to adjust antiplatelet therapy versus standard of care: rationale and design of the assessment with a double randomization of (1) a fixed dose versus a monitoringguided dose of aspirin and clopidogrel after DES implantation, and (2) treatment interruption versus continuation, 1 year after stenting (ARCTIC) study. Am Heart J 2011;161:5-12.e15.
4. Gurbel PA, Erlinge D, Ohman EM, Neely B, Neely M, Goodman SG, et al. Platelet function during extended prasugrel and clopidogrel therapy for patients with ACS treated without revascularization: the TRILOGY ACS platelet function substudy. JAMA 2012;308:1785-94.
5. Holmes DR Jr, Dehmer GJ, Kaul S, Leifer D, O'Gara PT, Stein CM. ACCF/AHA clopidogrel clinical alert: approaches to the FDA "boxed warning": A report of the American College of Cardiology Foundation Task Force on clinical expert consensus documents and the American Heart Association. Circulation 2010;122:537-57.